Axogen, Inc. — Director's Dealing 2017

Mar 15, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AxoGen, Inc. (AXGN)
CIK: 0000805928
Period of Report: 2016-12-30

Reporting Person: Freitag Gregory Gene (Director, General Counsel & SVP BD)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-12-30	Common Stock	M	23000	$2.74	Acquired	71901	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-12-30	Employee Stock Option (right to purchase)	$2.74	M	23000	Acquired	2018-12-26	Common Stock (92000)	Direct